Related Practice Areas

 

Choate Catches the Wave at BIO 2012

Choate Event Announcement

 | June 18, 2012

 

 

Preempting Patent Litigation with 3rd-Party Submissions, by Margaret Ives and Eric Marandett

Searching for Patent Drafting Pointers in Prometheus, by Charles Lyon

Ten Tips for Non-US Companies in Seeking US Venture Capital, by Stephen Hurwitz

Upping the Ante:  Recent Government Enforcement Trends Against the Pharmaceutical and Medical Device Industries, by Melissa Bayer Tearney

The Written Description Requirement:  Where Are We Now Post-Ariad?, by Eric Marandett

 

 

 

Choate represents major life sciences companies and institutions, including Bayer, Dana Farber, Harvard, Mass General Hospital, MIT and Wyeth/Pfizer, across the United States and in many foreign countries, offering a full range of sophisticated corporate, investment, IP and licensing services.  Read more...

 

Thank you for reaching out to contact Choate. Before you send your message, we wanted to make sure you are aware of the following. Please do not send any confidential information in response to this link. Sending an e-mail to Choate does not give rise to an attorney-client relationship, and will not be deemed to disqualify Choate from undertaking any engagement for a current or future client.  Before any attorney-client engagement may be formed, Choate will need to check for possible conflicts of interest, you will need to consider whether you wish to retain Choate as counsel, and we will need to consider whether we wish to accept the potential engagement. In the meantime, Choate reserves the right to represent parties with interests adverse to you.

AcceptDecline